製品の概要

  • 製品名Anti-HSPC142 antibody
    HSPC142 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to HSPC142
  • アプリケーション適用あり: IHC-P, IPmore details
    適用なし: WB
  • 種交差性
    交差種: Human
    交差が予測される動物種: Mouse, Rat, Horse, Cow, Dog, Pig, Chimpanzee, Rhesus monkey, Gorilla, Chinese Hamster, Orangutan, Elephant
  • 免疫原

    Synthetic peptide, corresponding to a region within amino acids 175-225 of Human HSPC142 (NP_054892.2).

  • ポジティブ・コントロール
    • Hela whole cell lysate

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • バッファーPreservative: 0.09% Sodium azide
    Constituent: Tris citrate/phosphate
    Note: pH 7 to 8
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • 特記事項(精製)ab115017 was affinity purified using an epitope specific to HSPC142 immobilized on solid support.
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab115017 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IHC-P 1/500 - 1/2000. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
IP Use at 2-5 µg/mg of lysate.
  • 追加情報Is unsuitable for WB.
  • ターゲット情報

    • 機能Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. In the BRCA1-A complex, it is required for the complex integrity and its localization at DSBs. Probably also plays a role as a component of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked ubiquitin. In these 2 complexes, it is probably required to maintain the stability of BRE/BRCC45 and help the 'Lys-63'-linked deubiquitinase activity mediated by BRCC3/BRCC36. component.
    • 配列類似性Belongs to the BABAM1 family.
    • ドメインThe VWFA-like region is similar to the VWFA domain. Its presence reveals similarities between the structure of the 19S proteasome and the BRCA1-A complexes.
    • 細胞内局在Cytoplasm. Nucleus. Localizes at sites of DNA damage at double-strand breaks.
    • Information by UniProt
    • 参照データベース
    • 別名
      • BABA1_HUMAN antibody
      • babam1 antibody
      • BRCA1 A complex subunit MERIT40 antibody
      • BRISC and BRCA1-A complex member 1 antibody
      • C19orf62 antibody
      • FLJ20571 antibody
      • HSPC142 antibody
      • hypothetical protein LOC29086 antibody
      • Mediator of Rap80 interactions and targeting 40 kDa antibody
      • Mediator of RAP80 interactions and targeting subunit of 40 kDa antibody
      • MERIT 40 antibody
      • MERIT40 antibody
      • NBA1 antibody
      • New component of the BRCA1 A complex antibody
      • New component of the BRCA1-A complex antibody
      • Uncharacterized protein C19orf62 antibody
      see all

    Anti-HSPC142 antibody 画像

    • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma tissue labelling HSPC142 with ab115017 at 1/1000 (1µg/ml). Detection: DAB.
    • Detection of HSPC142 by Western Blot of Immunprecipitate.
      anti-HSPC142, at 1 µg/ml, staining HSPC142 in Hela whole cell lysate immunoprecipitated using ab115017 at 3 µg/mg lysate (1 mg/IP; 20% of IP loaded/lane).
      Detection: Chemiluminescence with an exposure time of 10 seconds.

    Anti-HSPC142 antibody (ab115017) 使用論文

    ab115017 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab115017.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"